Merit Medical Systems Outlines Ongoing Succession Planning Process For Its CEO; Fred Lampropoulos Will Continue To Serve As CEO And President Through December 31, 2025

-0.65%

Merit Medical Systems, Inc.

MMSI

0.00

To carry out its responsibility for CEO succession, Merit Board of Directors appointed a special steering committee of independent directors led by Ann Millner, Ed.D., Lead Independent Director. The plan is also intended to prepare the company for a CEO transition at the appropriate time.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.